Riluzole |
Rilutek |
Riluzole is a drug used to treat amyotrophic lateral sclerosis. It delays the onset of ventilator-dependence in selected patients and may increase survival by approximately two months. A Cochrane Library review states a 9% gain in the probability of surviving one year. In secondary analyses of survival at separate time points, there was a significant survival advantage with Riluzole 100 mg at six, nine, 12 and 15 months, but not at three or 18 months. ...
... RILUZOLE (Rilutek®) slows down the progression of amyotrophic lateral sclerosis (also known as Lou Gehrig''s disease). Riluzole helps to delay the loss of muscle strength and limb function for several months; it is not a cure. It can slow the loss of respiratory function. Generic riluzole tablets are approved, but are not yet marketed in the US. ...
Riluzole Systematic (IUPAC) name 6-(trifluoromethoxy)benzothia ...

Not Signed In -

